Empresas CMPC (CMPC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Second quarter 2024 sales reached $1.888 billion, down 3% sequentially and 6% year-over-year, with EBITDA at $377 million (20% margin) and net income of $125 million, reflecting a 40% sequential decline but stable year-over-year performance.
Operating costs decreased 3% quarter-over-quarter and 14% year-over-year, representing 63% of revenues, driven by lower direct costs in pulp and cost control initiatives.
Free cash flow improved to a net outflow of $22 million, a significant recovery from the previous quarter.
The company maintained a focus on profitability, cost reductions, prudent capital allocation, and sustainability, with new ESG initiatives and community support.
Severe floods in Rio Grande do Sul, Brazil, disrupted logistics but did not damage assets; operations normalized in June.
Financial highlights
EBITDA margin for the quarter was 20%, with pulp contributing 62%, Softys 32%, and Biopackaging 6%.
Net debt stood at $4.761 billion, with a net debt to EBITDA ratio of 3.75x, improved from 4.03x last quarter.
Operating costs were $1.2 billion, representing 63% of revenues.
Investments totaled $146 million in Q2, down 67% year-over-year.
Free cash flow improved to a net outflow of $22 million, compared to $176 million in the previous quarter.
Outlook and guidance
Net debt to EBITDA is expected to continue improving, targeting a range within internal policy (2.5–3.5x) and aiming for below 2x before starting the Natureza Project.
CapEx for 2024 is projected around $600 million, with similar levels expected in 2025 to prepare for the Natureza Project.
Dividend policy for 2024 set at 30% of net distributable profit, with two interim dividends and a final dividend planned.
Pulp and tissue volumes are expected to normalize in the second half, with some recovery in Mexico but continued challenges in Brazil and Argentina.
Cost improvement programs in pulp are ongoing, with further reductions anticipated.
Latest events from Empresas CMPC
- Q4 2025 sales hit $1.9B, EBITDA $262M, net income $37M, with pulp leading growth.CMPC
Q4 20252 Feb 2026 - $4.5B Natureza project, cost cuts, and Softys growth drive sustainability and innovation.CMPC
Investor Day 202419 Jan 2026 - 3Q24 EBITDA and net income surged, driven by Pulp, with Softys lagging.CMPC
Q3 202415 Jan 2026 - Q4 2024: sales and net income declined, but EBITDA and leverage improved.CMPC
Q4 20249 Jan 2026 - Earnings and margins fell on lower pulp prices, but $1B in hybrid bonds improved liquidity.CMPC
Q3 202524 Nov 2025 - Q2 2025 saw $1.9B sales, EBITDA growth, asset sales, and major restructuring.CMPC
Q2 202523 Nov 2025 - Q1 2025: $1.813B sales, $278M EBITDA, $50M net income; Pulp strong, Softys and biopackaging pressured.CMPC
Q1 202519 Nov 2025 - CMPC seeks to modernize bond covenants while maintaining robust financial health and growth plans.CMPC
Corporate Presentation13 Jun 2025 - CMPC leads in pulp, tissue, and biopackaging with top sustainability and growth initiatives.CMPC
Corporate Presentation13 Jun 2025